Antimicrobial activity of thiamphenicol-glycinate-acetylcysteinate and other drugs against Chlamydia pneumoniae

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 3, 2001, Pages 264-267

  Lombardi, A ^a   Drago, L ^a   De Vecchi, E ^a   Mombelli, B ^a   Gismondo, M R ^a  

^a Laboratory of Microbiology LITA   (Italy)

Author keywords

Antimicrobial susceptibility; CAS 81103 11 9; Chlamydia pneumoniae; Chloramphenicol; Respiratory tract infections; Thiamphenicol glycinate acetylcysteinate

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; MACROLIDE; MUCOLYTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; THIAMPHENICOL GLYCINATE ACETYLCYSTEINATE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DRUG TISSUE LEVEL; IN VITRO STUDY; LUNG; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESPIRATORY TRACT INFECTION;

EID: 0035080094     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300034     Document Type: Article

References (19)

1. Antimicrobial susceptibility and therapy of infections caused by chlamydia pneumoniae
2. Pneumoniae due to chlamydia pneumoniae: Prevalence, clinical features, diagnosis and treatment
3. Chlamydia pneumoniae (Twar)
4. A new respiratory tract pathogen: Chlamydia pneumoniae strain Twar
5. The association of chlamydia pneumoniae infection and reactive airway disease in children
6. In vitro activities of Azithromycin, Clarithromycin, L-ofloxacin and others antibiotics against Chlamydia pneumoniae
7. In vitro activities of five quinolones against Chlamydia pneumoniae
8. In vitro activity of Chloramphenicol and Thiamphenicol analogs
9. Thiamphenicol and chloramphenicol: An in vitro comparison with particular references to bactericidal activity
10. Serum and lung levels of thaimphenicol after administration of its glycinate N-acetylcysteinate ester in experimentally infected guinea pigs
11. Effects of chloramphenicol and thiamphenicol on the outcome of Chlamydia psittaci infection in chick embryo
12. In vitro drug susceptibility of Chlamydia sp. strain Twar
13. Susceptibilities to Clarithromycin of isolates of Chlamydia pneumoniae from children with pneumonia
14. New oral macrolide and fluoroquinolone antibiotics: An overview of pharmacokinetics, interactions and safety
15. In vitro activities of Azithromicin and Doxycicline against 15 isolates of Chlamydia pneumonie
16. Tissue-directed pharmacokinetics
17. In vitro activities of Azithromycin, Clarithromycin, Erythromycin and Tetracicline against 13 strains of Chlamydia pneumoniae
18. In vitro Antibacterial activity of Thiamphenicol Glycinate Acetylcysteinate against Respiratory Pathogens